| Trial ID: | L0752 |
| Source ID: | NCT03919929
|
| Associated Drug: |
Semaglutide
|
| Title: |
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
|
| Acronym: |
TEAL
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
PCOS;Adolescent Obesity;NAFLD
|
| Interventions: |
Drug: Semaglutide 3mg and 7mg [Rybelsus];Other: Weight loss diet
|
| Outcome Measures: |
Change in Hepatic Fat FractionChange in Rate of De Novo Lipogenesis;Change in Whole Body Insulin Sensitivity;Change in Adipose Insulin Sensitivity
|
| Sponsor/Collaborators: |
University of Colorado, Denver
|
| Gender: |
Female
|
| Age: |
12 Years21 Years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
15/04/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
7 June 2021
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03919929
|
